Insiders Trades

★ Sign in to follow

RD

Rene David

Abattis Bioceuticals Corp.

Cumul. flow

Total declarations

41

Company

1

▲ Purchases (1 ops.)

€13k

▼ Sales (4 ops.)

€70k

Latest filing published 27 Jun 2018 for Abattis Bioceuticals Corp., €352k.

Filing timeline

BuySale

Rene David

Insider track record

Disclosed buys

1

Disclosed sells

4

Signal history

Rene David: trading record in brief

All filings by Rene David on record concern Abattis Bioceuticals Corp. The record holds 41 filings, for trades running from 17 March 2015 to 26 June 2018.

The open-market side counts 1 purchase for €13k alongside 4 sales for €70k. Sales outweigh purchases by €57k. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. The rest of the record consists of 28 share grants.

The latest filing, published on 27 June 2018, reports a share grant of €352k in Abattis Bioceuticals Corp. The clock since the last published purchase (15 January 2017) now reads 3,569 days. Filings reach the SEDI feed a median of 4 days after the trade. This delay matters because a trade only becomes useful information once it is public. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Source: insider filings from SEDI. Past trades are no guide to future returns.

Companies and markets linked to Rene David

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Abattis Bioceuticals Corp. (CA)

Declarations40 total

◆

5 - Senior Officer of IssuerExecutives26 Jun 2018Abattis Bioceuticals Corp.

545,377 CAD12SEDI

4,277,465 shares@ CA$0.127514.9% of flowCommon SharesTSXSEDI:3202514

◆

5 - Senior Officer of IssuerExecutives26 Jun 2018Abattis Bioceuticals Corp.

146,200 CAD11SEDI

1,000,000 shares@ CA$0.14624.0% of flowCommon SharesTSXSEDI:3202511

●

5 - Senior Officer of IssuerExecutives19 Jun 2018Abattis Bioceuticals Corp.

170,000 CAD11SEDI

1,000,000 shares@ CA$0.174.7% of flowCommon SharesTSXSEDI:3200381

●

5 - Senior Officer of IssuerExecutives19 Jun 2018Abattis Bioceuticals Corp.

0SEDI

1,500,000 sharesCommon SharesTSXSEDI:3199469

◆

5 - Senior Officer of IssuerExecutives12 Mar 2018Abattis Bioceuticals Corp.

810,000 CAD13SEDI

3,000,000 shares@ CA$0.2721.8% of flowCommon SharesTSXSEDI:3152922

◆

5 - Senior Officer of IssuerExecutives13 Feb 2018Abattis Bioceuticals Corp.

1M CAD14SEDI

4,500,000 shares@ CA$0.262532.3% of flowCommon SharesTSXSEDI:3132961

◆

5 - Senior Officer of IssuerExecutives16 Jan 2018Abattis Bioceuticals Corp.

122,743 CAD11SEDI

762,379 shares@ CA$0.1613.4% of flowCommon SharesTSXSEDI:3119571

◆

5 - Senior Officer of IssuerExecutives18 Dec 2017Abattis Bioceuticals Corp.

15,750 CAD13SEDI

36,627 shares@ CA$0.430.4% of flowCommon SharesTSXSEDI:3102768

▼

5 - Senior Officer of IssuerExecutives12 Dec 2017Abattis Bioceuticals Corp.

30,360 CAD13SEDI

66,000 shares@ CA$0.460.8% of flowCommon SharesTSXSEDI:3098091

●

5 - Senior Officer of IssuerExecutives6 Dec 2017Abattis Bioceuticals Corp.

0SEDI

1,046,667 sharesCommon SharesTSXSEDI:3094010

◆

5 - Senior Officer of IssuerExecutives30 Oct 2017Abattis Bioceuticals Corp.

13,745 CAD13SEDI

99,099 shares@ CA$0.13870.4% of flowCommon SharesTSXSEDI:3076101

◆

5 - Senior Officer of IssuerExecutives11 Sept 2017Abattis Bioceuticals Corp.

14,500 CAD13SEDI

100,000 shares@ CA$0.1450.4% of flowCommon SharesTSXSEDI:3057443

◆

5 - Senior Officer of IssuerExecutives11 Sept 2017Abattis Bioceuticals Corp.

5,247 CAD13SEDI

48,275 shares@ CA$0.10870.1% of flowCommon SharesTSXSEDI:3057444

●

5 - Senior Officer of IssuerExecutives24 Aug 2017Abattis Bioceuticals Corp.

0SEDI

200,000 sharesCommon SharesTSXSEDI:3052063

◆

5 - Senior Officer of IssuerExecutives24 Aug 2017Abattis Bioceuticals Corp.

5,247 CAD13SEDI

60,869 shares@ CA$0.08620.1% of flowCommon SharesTSXSEDI:3052058

◆

5 - Senior Officer of IssuerExecutives24 Aug 2017Abattis Bioceuticals Corp.

23,000 CAD13SEDI

200,000 shares@ CA$0.1150.6% of flowCommon SharesTSXSEDI:3052059

◆

5 - Senior Officer of IssuerExecutives12 Jul 2017Abattis Bioceuticals Corp.

72,500 CAD15SEDI

500,000 shares@ CA$0.1452.0% of flowCommon SharesTSXSEDI:3036864

◆

5 - Senior Officer of IssuerExecutives12 Jul 2017Abattis Bioceuticals Corp.

5,247 CAD15SEDI

48,275 shares@ CA$0.10870.1% of flowCommon SharesTSXSEDI:3036865

◆

5 - Senior Officer of IssuerExecutives12 Jun 2017Abattis Bioceuticals Corp.

92,500 CAD14SEDI

500,000 shares@ CA$0.18525.7% of flowCommon SharesTSXSEDI:3022963

◆

5 - Senior Officer of IssuerExecutives12 Jun 2017Abattis Bioceuticals Corp.

5,248 CAD11SEDI

37,837 shares@ CA$0.13871.5% of flowCommon SharesTSXSEDI:3021809

◆

5 - Senior Officer of IssuerExecutives20 Apr 2017Abattis Bioceuticals Corp.

117,967 CAD14SEDI

669,504 shares@ CA$0.176233.8% of flowCommon SharesTSXSEDI:2999952

●

5 - Senior Officer of IssuerExecutives17 Mar 2015Abattis Bioceuticals Corp.

0SEDI

200,000 sharesCommon SharesTSXSEDI:2999951

◆

5 - Senior Officer of IssuerExecutives12 Apr 2017Abattis Bioceuticals Corp.

80,250 CAD13SEDI

535,000 shares@ CA$0.1523.5% of flowCommon SharesTSXSEDI:2996911

▼

5 - Senior Officer of IssuerExecutives10 Mar 2017Abattis Bioceuticals Corp.

30,000 CAD12SEDI

200,000 shares@ CA$0.158.7% of flowCommon SharesTSXSEDI:2976607

▼

5 - Senior Officer of IssuerExecutives10 Mar 2017Abattis Bioceuticals Corp.

13,175 CAD11SEDI

85,000 shares@ CA$0.1553.8% of flowCommon SharesTSXSEDI:2976609

25 of 40 declarations